{"avg":{"avg_bot_access":91.6,"avg_rendering":93,"avg_structure":35.3,"avg_schema":9.4,"avg_tech_stack":63.4,"avg_overall":56.8},"domain":{"domain":"akdae.de","crawled_at":"2026-03-19T03:54:42.876617Z","gptbot_allowed":true,"claudebot_allowed":true,"ccbot_allowed":true,"google_extended_allowed":true,"googlebot_allowed":true,"raw_text_length":10284,"rendered_text_length":10284,"ghost_ratio":0,"rendering_type":"SSR","word_count":858,"li_count":71,"tr_count":0,"th_count":0,"structure_score":8.279999732971191,"has_org_schema":true,"has_product_schema":false,"schema_count":1,"tech_stack":"typo3","server_header":"Apache","cdn":"","http_status":200,"load_time_ms":657,"total_html_bytes":50677,"useful_text_bytes":10284,"token_bloat_ratio":4.900000095367432,"images_total":7,"images_with_alt":4,"multimodal_pct":57,"tdm_reservation":false,"has_noai_tag":false,"script_bytes":1473,"has_breadcrumb_schema":false,"has_faq_schema":false,"has_article_schema":false,"has_website_schema":false,"page_title":"Arzneimittelkommission der deutschen Ärzteschaft","logo_url":"https://akdae.de/_assets/b640b59ed477862f30a01721df666008/Images/favicon.ico","crawl_blocked":false,"ai_readiness_score":78,"sub_bot_access":100,"sub_rendering":100,"sub_structure":53,"sub_schema":42,"sub_tech_stack":60,"extractability_score":71,"crawl_cost_score":10,"crawl_cost_label":"Low","blocklist_risk":0,"blocklist_risk_label":"None","acri_score":59,"acri_extractability":81,"acri_semantic_structure":54,"acri_content_integrity":60,"acri_retrieval_robustness":37,"acri_grade":"C","h2_texts":"Unerwünschte Arzneimittelwirkung | Aktionsplan Arzneimitteltherapiesicherheit | Unerwünschte Arzneimittelwirkung melden | Neue Arzneimittel | Nutzenbewertung § 35a SGB V | Aktuelle Meldungen | Colecalciferol (Vitamin D3) / Fluorid – sichere Anwendung von Tabletten zur Rachitis- und/oder Kariesprophylaxe bei Säuglingen und Kleinkindern | Stellungnahme der AkdÄ zur frühen Nutzenbewertung § 35a SGB V: Donanemab (Kisunla®) | Änderung der Fach- und Gebrauchsinformationen aufgrund von PSUR Single Assessment-Verfahren | Stellungnahmen der AkdÄ zur frühen Nutzenbewertung § 35a SGB V: Concizumab (Alhemo®), Tislelizumab (Tevimbra®)","tranco_rank":329937,"title_length":49,"meta_desc_length":0,"has_canonical":true,"canonical_url":"https://www.akdae.de/","canonical_mismatch":false,"has_meta_viewport":true,"h1_count":0,"h2_count":17,"h2_before_h1":true,"has_hreflang":false,"has_noindex":false,"has_lang_attr":true,"lang_attr":"de","og_image":"https://www.akdae.de/_assets/b640b59ed477862f30a01721df666008/Images/socialmedia-placeholder-facebook.jpg","twitter_card":"summary","ttfb_ms":657,"dom_node_count":648,"html_payload_kb":49.5,"has_hsts":true,"has_csp":false,"cache_control":"no-cache, must-revalidate","sitemap_declared":true,"sitemap_url":"https://www.akdae.de/sitemap.xml","internal_links":95,"external_links":1,"tracker_scripts":0,"tracker_token_pct":0,"global_score":68,"seo_pillar":25,"geo_pillar":81,"perf_pillar":80,"arch_pillar":86,"data_tier":1,"ai_trust_score":0,"ai_trust_rank":62986,"ai_trust_percentile":0,"inbound_ai_links":1,"outbound_ai_links":0,"llm_analyzed":true,"llm_analyzed_at":"2026-03-15T17:11:41.252041Z","llm_model":"mlx-community/gemma-3-4b-it-qat-4bit","ai_unified_analysis":{"core_offering":"This platform provides resources and tools for managing adverse drug reactions and ensuring medication safety.","target_audience":"Pharmacists, physicians, regulatory agencies, and healthcare professionals involved in drug safety.","pricing_model":"SEMANTIC VOID","integration_partners":[],"compliance_standards":[],"competitive_moat":"Focus on drug safety and regulatory compliance within the German healthcare system.","content_depth_score":3}},"percentile":88,"similar_domains":[{"domain":"winemeridian.com","acri_score":69,"ai_readiness_score":82,"tech_stack":"wordpress","category":"infrastructure","token_bloat_ratio":5.199999809265137,"schema_count":1,"distance":21.58999991416931,"page_title":"Wine Meridian","h1_text":"Il primo magazine online italiano per orientarti nel mondo del vino"},{"domain":"tjad.takarajimasha.tkj.jp","acri_score":69,"ai_readiness_score":90,"tech_stack":"wordpress","category":"infrastructure","token_bloat_ratio":5.800000190734863,"schema_count":1,"distance":21.77000002861023,"page_title":"宝島社広告局","h1_text":""},{"domain":"forte.jor.br","acri_score":69,"ai_readiness_score":80,"tech_stack":"wordpress","category":"infrastructure","token_bloat_ratio":3.700000047683716,"schema_count":1,"distance":21.860000014305115,"page_title":"Home - Forças Terrestres","h1_text":"Forças Terrestres"},{"domain":"koncon.nl","acri_score":69,"ai_readiness_score":81,"tech_stack":"proprietary","category":"infrastructure","token_bloat_ratio":2.5999999046325684,"schema_count":1,"distance":22.19000005722046,"page_title":"Home | Koninklijk Conservatorium Den Haag","h1_text":""},{"domain":"cbsetuts.com","acri_score":69,"ai_readiness_score":78,"tech_stack":"wordpress","category":"infrastructure","token_bloat_ratio":7.5,"schema_count":1,"distance":22.27999997138977,"page_title":"NCERT Solutions | NCERT Exemplar Solutions - CBSETuts.com","h1_text":""}]}